• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人结肠腺癌中72,000分子量IV型胶原酶表达增加。

Increased expression of the Mr 72,000 type IV collagenase in human colonic adenocarcinoma.

作者信息

Levy A T, Cioce V, Sobel M E, Garbisa S, Grigioni W F, Liotta L A, Stetler-Stevenson W G

机构信息

Tumor Invasion and Metastasis Section, National Cancer Institute Bethesda, Maryland 20892.

出版信息

Cancer Res. 1991 Jan 1;51(1):439-44.

PMID:1846313
Abstract

Proteolytic enzymes, such as type IV collagenase, play an important role in tumor invasion and metastasis. To examine Mr 72,000 type IV collagenase expression in human colon carcinoma, blot hybridization of total RNA from 19 primary colon tumors were performed. These filters were probed with complementary DNA probes encoding the Mr 72,000 type IV collagenase metalloenzyme. The results were expressed as the ratio of the messenger RNA (mRNA) levels in the tumor tissue to that in the adjacent normal mucosa (R). The level of the 3.1-kilobase type IV collagenase mRNA was higher in the primary tumor than in the normal adjacent colonic mucosa in 13 of 18 (72%) cases with a diagnosis of adenocarcinoma. These cases were divided into high expression (R, 4.50 to 29.34) and intermediate expression (R, 2.54 to 3.31) subgroups. Both groups showed statistically significant (P less than 0.05) elevations when compared with the five cases showing the lowest levels of Mr 72,000 type IV collagenase mRNA expression (low expression subgroup; R, 0.96 to 1.48). With this demonstrated elevation of Mr 72,000 type IV collagenase mRNA in colorectal adenocarcinoma we examined concomitant expression at the protein level using immunohistochemical techniques. Immunohistochemical examination of 70 cases of colon tumors, including 30 benign adenomas, using anti-Mr 72,000 type IV collagenase antibodies demonstrated a significant correlation with Duke's classification (P less than 0.001). Our results suggest that enhanced expression of the Mr 72,000 type IV collagenase enzyme may be a marker of human colorectal tumor invasiveness.

摘要

蛋白水解酶,如IV型胶原酶,在肿瘤侵袭和转移中起重要作用。为检测人结肠癌中72000分子量IV型胶原酶的表达,对19例原发性结肠肿瘤的总RNA进行了印迹杂交。这些滤膜用编码72000分子量IV型胶原酶金属酶的互补DNA探针进行检测。结果以肿瘤组织中信使核糖核酸(mRNA)水平与相邻正常黏膜中mRNA水平的比值(R)表示。在18例诊断为腺癌的病例中,有13例(72%)原发性肿瘤中3.1千碱基IV型胶原酶mRNA水平高于相邻正常结肠黏膜。这些病例分为高表达(R,4.50至29.34)和中等表达(R,2.54至3.31)亚组。与5例72000分子量IV型胶原酶mRNA表达水平最低的病例(低表达亚组;R,0.96至1.48)相比,两组均显示出统计学上的显著升高(P小于0.05)。鉴于已证实在结直肠癌中72000分子量IV型胶原酶mRNA升高,我们使用免疫组织化学技术检测了其在蛋白质水平的伴随表达。使用抗72000分子量IV型胶原酶抗体对70例结肠肿瘤(包括30例良性腺瘤)进行免疫组织化学检查,结果显示与杜克分期有显著相关性(P小于0.001)。我们的结果表明,72000分子量IV型胶原酶的表达增强可能是人结肠肿瘤侵袭性的一个标志物。

相似文献

1
Increased expression of the Mr 72,000 type IV collagenase in human colonic adenocarcinoma.人结肠腺癌中72,000分子量IV型胶原酶表达增加。
Cancer Res. 1991 Jan 1;51(1):439-44.
2
Independent expression and cellular processing of Mr 72,000 type IV collagenase and interstitial collagenase in human tumorigenic cell lines.人致瘤细胞系中72,000分子量IV型胶原酶和间质胶原酶的独立表达及细胞加工过程
Cancer Res. 1990 Oct 1;50(19):6184-91.
3
Expression of 72 kilodalton type IV collagenase (gelatinase A) in benign and malignant ovarian tumors.72千道尔顿IV型胶原酶(明胶酶A)在卵巢良恶性肿瘤中的表达
Lab Invest. 1993 Sep;69(3):312-21.
4
Simultaneous expression of 70 kilodalton type IV collagenase and type IV collagen alpha 1 (IV) chain genes by cells of early human placenta and gestational endometrium.70千道尔顿IV型胶原酶和IV型胶原α1(IV)链基因在人早期胎盘和妊娠子宫内膜细胞中的同时表达。
Lab Invest. 1992 Aug;67(2):191-200.
5
Increased expression of the 72-kd type IV collagenase in prostatic adenocarcinoma. Demonstration by immunohistochemistry and in situ hybridization.72-kd Ⅳ型胶原酶在前列腺腺癌中的表达增加。免疫组织化学和原位杂交证实。
Am J Pathol. 1994 Mar;144(3):585-91.
6
Localization of messenger RNA for Mr 72,000 and 92,000 type IV collagenases in human skin cancers by in situ hybridization.通过原位杂交对人皮肤癌中72,000和92,000型IV型胶原酶信使核糖核酸进行定位
Cancer Res. 1992 Mar 1;52(5):1336-41.
7
Expression of a Mr 32,000 laminin-binding protein messenger RNA in human colon carcinoma correlates with disease progression.一种分子量为32,000的层粘连蛋白结合蛋白信使核糖核酸在人结肠癌中的表达与疾病进展相关。
Cancer Res. 1990 Jul 1;50(13):3888-91.
8
The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.结直肠癌进展过程中腺瘤-癌序列中血管内皮生长因子(VEGF)-A、VEGF-B、VEGF-C和VEGF-D的血管生成开关。
J Pathol. 2003 Jun;200(2):183-94. doi: 10.1002/path.1339.
9
Expression of matrix metalloproteinase-1 in human colorectal carcinoma.基质金属蛋白酶-1在人大肠癌中的表达
Mod Pathol. 2000 Sep;13(9):925-33. doi: 10.1038/modpathol.3880169.
10
Type IV collagenase (M(r) 72,000) expression in human prostate: benign and malignant tissue.IV型胶原酶(分子量72,000)在人前列腺中的表达:良性和恶性组织
Cancer Res. 1993 Feb 15;53(4):878-83.

引用本文的文献

1
Matrix Metalloproteinases 2 and 9 Polymorphism in Patients With Myeloproliferative Diseases: A STROBE-Compliant Observational Study.骨髓增殖性疾病患者基质金属蛋白酶2和9基因多态性:一项符合STROBE标准的观察性研究
Medicine (Baltimore). 2015 Apr;94(16):e732. doi: 10.1097/MD.0000000000000732.
2
1‑calcium phosphate‑uracil, a synthesized pyrimidine derivative agent, has anti‑proliferative, pro‑apoptotic and anti‑invasion effects on multiple tumor cell lines.1-磷酸钙-尿嘧啶,一种合成的嘧啶衍生物制剂,对多种肿瘤细胞系具有抗增殖、促凋亡和抗侵袭作用。
Mol Med Rep. 2014 Nov;10(5):2271-8. doi: 10.3892/mmr.2014.2489. Epub 2014 Aug 14.
3
Matrix metalloproteinases: changing roles in tumor progression and metastasis.
基质金属蛋白酶:在肿瘤进展和转移中的变化作用。
Am J Pathol. 2012 Dec;181(6):1895-9. doi: 10.1016/j.ajpath.2012.08.044. Epub 2012 Oct 12.
4
Development of macromolecular prodrug for rheumatoid arthritis.类风湿性关节炎的大分子前药的开发。
Adv Drug Deliv Rev. 2012 Sep;64(12):1205-19. doi: 10.1016/j.addr.2012.03.006. Epub 2012 Mar 10.
5
Late SV40 factor (LSF) enhances angiogenesis by transcriptionally up-regulating matrix metalloproteinase-9 (MMP-9).晚期 SV40 因子 (LSF) 通过转录上调基质金属蛋白酶-9 (MMP-9) 促进血管生成。
J Biol Chem. 2012 Jan 27;287(5):3425-32. doi: 10.1074/jbc.M111.298976. Epub 2011 Dec 13.
6
RNAi-mediated downregulation of urokinase plasminogen activator receptor and matrix metalloprotease-9 in human breast cancer cells results in decreased tumor invasion, angiogenesis and growth.RNA干扰介导的人乳腺癌细胞中尿激酶型纤溶酶原激活物受体和基质金属蛋白酶-9的下调导致肿瘤侵袭、血管生成和生长减少。
Int J Cancer. 2007 Nov 15;121(10):2307-16. doi: 10.1002/ijc.22962.
7
Ornithine decarboxylase, mitogen-activated protein kinase and matrix metalloproteinase-2 expressions in human colon tumors.鸟氨酸脱羧酶、丝裂原活化蛋白激酶和基质金属蛋白酶-2在人结肠肿瘤中的表达
World J Gastroenterol. 2005 May 28;11(20):3065-9. doi: 10.3748/wjg.v11.i20.3065.
8
Matrix metalloproteinase-2 (MMP-2) is associated with survival in breast carcinoma.基质金属蛋白酶-2(MMP-2)与乳腺癌患者的生存率相关。
Br J Cancer. 2003 Oct 6;89(7):1270-5. doi: 10.1038/sj.bjc.6601238.
9
Changes in matrix metalloproteinases and their endogenous inhibitors during tumor progression in the uterine cervix.子宫颈肿瘤进展过程中基质金属蛋白酶及其内源性抑制剂的变化。
J Cancer Res Clin Oncol. 2003 Feb;129(2):123-31. doi: 10.1007/s00432-002-0411-9. Epub 2003 Feb 19.
10
Multiparametric in situ mRNA hybridization analysis of gastric biopsies predicts lymph node metastasis in patients with gastric carcinoma.胃癌患者胃活检组织的多参数原位mRNA杂交分析可预测淋巴结转移。
Jpn J Cancer Res. 2002 Nov;93(11):1258-65. doi: 10.1111/j.1349-7006.2002.tb01232.x.